Last reviewed · How we verify

1.0% Icotinib hydrochloride cream

Betta Pharmaceuticals Co., Ltd. · Phase 1 active Small molecule Quality 0/100

1.0% Icotinib hydrochloride cream is a Small molecule drug developed by Betta Pharmaceuticals Co., Ltd.. It is currently in Phase 1 development. Also known as: no other name.

At a glance

Generic name1.0% Icotinib hydrochloride cream
Also known asno other name
SponsorBetta Pharmaceuticals Co., Ltd.
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about 1.0% Icotinib hydrochloride cream

What is 1.0% Icotinib hydrochloride cream?

1.0% Icotinib hydrochloride cream is a Small molecule drug developed by Betta Pharmaceuticals Co., Ltd..

Who makes 1.0% Icotinib hydrochloride cream?

1.0% Icotinib hydrochloride cream is developed by Betta Pharmaceuticals Co., Ltd. (see full Betta Pharmaceuticals Co., Ltd. pipeline at /company/betta-pharmaceuticals-co-ltd).

Is 1.0% Icotinib hydrochloride cream also known as anything else?

1.0% Icotinib hydrochloride cream is also known as no other name.

What development phase is 1.0% Icotinib hydrochloride cream in?

1.0% Icotinib hydrochloride cream is in Phase 1.

Related